• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胸膜间皮瘤组织病理学亚型的可重复性。

Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.

机构信息

From the Institute of Pathology (Dr Brcic) and the Institute for Medical Informatics, Statistics and Documentation (Dr Quehenberger), Medical University of Graz, Graz, Austria; and Cytology and Pathology Laboratory, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia (Drs Vlacic and Kern).

出版信息

Arch Pathol Lab Med. 2018 Jun;142(6):747-752. doi: 10.5858/arpa.2017-0295-OA. Epub 2018 Mar 6.

DOI:10.5858/arpa.2017-0295-OA
PMID:29509030
Abstract

CONTEXT

  • Malignant pleural mesothelioma (MPM) is a rare tumor with poor prognosis. Several studies have analyzed potential prognostic markers, but histologic type remains the single most important prognostic factor. Histologic subtypes of epithelioid MPM seem to have prognostic and therapeutic implications. Interobserver agreement in histologic pattern classification should be high.

OBJECTIVE

  • To assess interobserver and intraobserver reproducibility in histologic differentiation between the main types of MPMs, and in further subtyping of epithelioid-type mesothelioma.

DESIGN

  • One representative hematoxylin-eosin-stained slide was selected from the archive for each of 200 patients with MPM. They were reviewed independently by 3 pathologists and classified according to the current World Health Organization classification of pleural tumors. After the first round of evaluations, a consensus meeting was organized where problems were addressed and representative images for each histologic category were selected. Two months later, cases were reevaluated by all 3 pathologists.

RESULTS

  • After the first round, overall interobserver agreement for histologic subtyping of mesothelioma was fair (κ, 0.36). The agreement was increased to substantial (κ, 0.63) in the second round. Improvement was found in interobserver agreement for all types of MPM and for most epithelioid subtypes.

CONCLUSIONS

  • Moderate to substantial agreement in histologic typing and subtyping of MPM can be achieved. However, training with additional clarification of diagnostic criteria, their strict application, and help from consensus-based illustrative images is needed.
摘要

背景

  • 恶性胸膜间皮瘤(MPM)是一种预后不良的罕见肿瘤。有几项研究分析了潜在的预后标志物,但组织学类型仍然是最重要的单一预后因素。上皮样 MPM 的组织学亚型似乎具有预后和治疗意义。组织学模式分类的观察者间一致性应该很高。

目的

  • 评估观察者间和观察者内对 MPM 主要类型之间的组织学差异以及上皮样型间皮瘤的进一步亚型分类的一致性。

设计

  • 从 MPM 患者的档案中为每个患者选择一张代表性的苏木精-伊红染色幻灯片。由 3 位病理学家独立进行审查,并根据当前的胸膜肿瘤世界卫生组织分类进行分类。在第一轮评估后,组织了一次共识会议,解决了问题,并为每个组织学类别选择了代表性图像。两个月后,所有 3 位病理学家重新评估了病例。

结果

  • 在第一轮后,间皮瘤组织学亚型的总体观察者间一致性为中等(κ,0.36)。第二轮的一致性增加到显著(κ,0.63)。所有 MPM 类型和大多数上皮样亚型的观察者间一致性均有所提高。

结论

  • 可以实现 MPM 的组织学分型和亚型的中等至显著一致性。然而,需要通过额外澄清诊断标准、严格应用这些标准以及基于共识的说明性图像来进行培训。

相似文献

1
Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.恶性胸膜间皮瘤组织病理学亚型的可重复性。
Arch Pathol Lab Med. 2018 Jun;142(6):747-752. doi: 10.5858/arpa.2017-0295-OA. Epub 2018 Mar 6.
2
Reproducibility of histological subtyping of malignant pleural mesothelioma.恶性胸膜间皮瘤组织学亚型的可重复性
Virchows Arch. 2014 Dec;465(6):679-85. doi: 10.1007/s00428-014-1664-9. Epub 2014 Oct 10.
3
Interobserver Agreement in Histopathological Subtyping of Malignant Pleural Mesotheliomas.恶性胸膜间皮瘤组织学分型的观察者间一致性。
Turk Patoloji Derg. 2021;37(1):56-62. doi: 10.5146/tjpath.2020.01498.
4
New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.双相性间皮瘤诊断可重复性的新见解:来自 MESOPATH 参考中心的国际间皮瘤专家组的多机构评估。
J Thorac Oncol. 2018 Aug;13(8):1189-1203. doi: 10.1016/j.jtho.2018.04.023. Epub 2018 Apr 30.
5
Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value.恶性胸膜间皮瘤的细胞学诊断:诊断标准、WHO 分类更新和免疫组织化学染色标记物的诊断价值。
Diagn Cytopathol. 2022 Nov;50(11):532-537. doi: 10.1002/dc.25053. Epub 2022 Sep 7.
6
Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes.恶性胸膜间皮瘤的弥散加权 MRI:组织学亚型中表观弥散系数的初步评估。
AJR Am J Roentgenol. 2010 Aug;195(2):W125-30. doi: 10.2214/AJR.09.3519.
7
BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.BAP1有助于提高恶性胸膜间皮瘤诊断的客观性、分类及预后评估。
Hum Pathol. 2015 Nov;46(11):1670-8. doi: 10.1016/j.humpath.2015.06.024. Epub 2015 Jul 21.
8
c-Met expression and MET amplification in malignant pleural mesothelioma.恶性胸膜间皮瘤中的c-Met表达与MET扩增
Ann Diagn Pathol. 2016 Aug;23:1-7. doi: 10.1016/j.anndiagpath.2016.04.007. Epub 2016 Apr 30.
9
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.恶性胸膜间皮瘤的病理分级:循证建议。
J Thorac Oncol. 2018 Nov;13(11):1750-1761. doi: 10.1016/j.jtho.2018.07.002. Epub 2018 Jul 7.
10
Accuracy of pleural biopsy for the diagnosis of histologic subtype of malignant pleural mesothelioma: Necropsy-based study of 134 cases.胸膜活检对恶性胸膜间皮瘤组织学亚型诊断的准确性:134 例尸检研究。
Tumori. 2022 Feb;108(1):26-32. doi: 10.1177/0300891620988354. Epub 2021 Mar 15.

引用本文的文献

1
An Evaluation Into the Robustness of Grading of Pleural Mesothelioma Outside of Specialist Centres.对专科中心以外的胸膜间皮瘤分级稳健性的评估。
APMIS. 2025 Mar;133(3):e70006. doi: 10.1111/apm.70006.
2
Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.胸膜间皮瘤病理诊断方法中的挑战
Cancers (Basel). 2025 Feb 1;17(3):481. doi: 10.3390/cancers17030481.
3
Diagnosis of Pleural Mesothelioma: Is Everything Solved at the Present Time?胸膜间皮瘤的诊断:目前是否一切都已解决?
Curr Oncol. 2024 Aug 27;31(9):4968-4983. doi: 10.3390/curroncol31090368.
4
Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations.通过病例介绍突出恶性间皮瘤亚型的免疫组织化学差异。
Thorac Cancer. 2023 Apr;14(10):857-863. doi: 10.1111/1759-7714.14827. Epub 2023 Feb 20.
5
New Insights in Pleural Mesothelioma Classification Update: Diagnostic Traps and Prognostic Implications.胸膜间皮瘤分类更新的新见解:诊断陷阱与预后意义
Diagnostics (Basel). 2022 Nov 22;12(12):2905. doi: 10.3390/diagnostics12122905.
6
Adenomatoid mesothelioma arising from the diaphragm: a case report and review of the literature.来源于膈肌的腺瘤样间皮瘤:病例报告及文献复习。
J Med Case Rep. 2022 May 30;16(1):228. doi: 10.1186/s13256-022-03420-9.
7
Pleural mesothelioma classification-update and challenges.胸膜间皮瘤分类——更新与挑战
Mod Pathol. 2022 Jan;35(Suppl 1):51-56. doi: 10.1038/s41379-021-00895-7. Epub 2021 Aug 31.
8
Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.2000年至2016年美国恶性胸膜间皮瘤的流行病学情况
Cureus. 2021 Apr 21;13(4):e14605. doi: 10.7759/cureus.14605.
9
Pleural mesothelioma classification update.胸膜间皮瘤分类更新。
Virchows Arch. 2021 Jan;478(1):59-72. doi: 10.1007/s00428-021-03031-7. Epub 2021 Jan 21.
10
Interobserver Agreement in Histopathological Subtyping of Malignant Pleural Mesotheliomas.恶性胸膜间皮瘤组织学分型的观察者间一致性。
Turk Patoloji Derg. 2021;37(1):56-62. doi: 10.5146/tjpath.2020.01498.